Inhibition of tryptophan 2,3-dioxygenase impairs DNA damage tolerance and repair in glioma cells.


Journal

NAR cancer
ISSN: 2632-8674
Titre abrégé: NAR Cancer
Pays: England
ID NLM: 101769553

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 06 11 2020
revised: 15 03 2021
accepted: 23 03 2021
entrez: 19 4 2021
pubmed: 20 4 2021
medline: 20 4 2021
Statut: epublish

Résumé

Expression of tryptophan 2,3-dioxygenase (TDO) is a determinant of malignancy in gliomas through kynurenine (KYN) signaling. We report that inhibition of TDO activity attenuated recovery from replication stress and increased the genotoxic effects of bis-chloroethylnitrosourea (BCNU). Activation of the Chk1 arm of the replication stress response (RSR) was reduced when TDO activity was blocked prior to BCNU treatment, whereas phosphorylation of serine 33 (pS33) on replication protein A (RPA) was enhanced-indicative of increased fork collapse. Analysis of quantitative proteomic results revealed that TDO inhibition reduced nuclear 53BP1 and sirtuin levels. We confirmed that cells lacking TDO activity exhibited elevated gamma-H2AX signal and defective recruitment of 53BP1 to chromatin following BCNU treatment, which corresponded with delayed repair of DNA breaks. Addition of exogenous KYN increased the rate of break repair. TDO inhibition diminished SIRT7 deacetylase recruitment to chromatin, which increased histone H3K18 acetylation-a key mark involved in preventing 53BP1 recruitment to sites of DNA damage. TDO inhibition also sensitized cells to ionizing radiation (IR)-induced damage, but this effect did not involve altered 53BP1 recruitment. These experiments support a model where TDO-mediated KYN signaling helps fuel a robust response to replication stress and DNA damage.

Identifiants

pubmed: 33870196
doi: 10.1093/narcan/zcab014
pii: zcab014
pmc: PMC8034706
doi:

Types de publication

Journal Article

Langues

eng

Pagination

zcab014

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM121293
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003107
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of NAR Cancer.

Références

Sci Adv. 2019 Mar 27;5(3):eaav1118
pubmed: 30944854
Elife. 2018 Nov 13;7:
pubmed: 30422114
Front Immunol. 2019 Dec 04;10:2762
pubmed: 31866995
Nature. 2011 Oct 05;478(7368):197-203
pubmed: 21976023
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Molecules. 2018 Jan 17;23(1):
pubmed: 29342113
Lancet Oncol. 2019 Aug;20(8):1083-1097
pubmed: 31221619
EMBO J. 2013 Jul 31;32(15):2172-85
pubmed: 23799366
Ann Oncol. 2010 May;21 Suppl 5:v190-3
pubmed: 20555079
Neuro Oncol. 2017 Oct 1;19(10):1316-1326
pubmed: 28419303
Science. 2017 Jul 28;357(6349):
pubmed: 28751584
Nat Rev Mol Cell Biol. 2016 May;17(5):308-21
pubmed: 26956196
Neuro Oncol. 2017 Feb 1;19(2):153-161
pubmed: 27282398
Genes Dev. 2017 Jul 1;31(13):1370-1381
pubmed: 28790157
J Cell Sci. 2009 Nov 15;122(Pt 22):4070-80
pubmed: 19843584
Cancer Res. 2016 Apr 15;76(8):2340-53
pubmed: 26960975
Chem Res Toxicol. 2016 Jan 19;29(1):101-8
pubmed: 26651356
Handb Clin Neurol. 2016;134:381-97
pubmed: 26948367
J Neurochem. 2016 Mar;136(6):1142-1154
pubmed: 26708701
Bioinformatics. 2014 Oct;30(19):2757-63
pubmed: 24907368
Nat Commun. 2019 Nov 21;10(1):5284
pubmed: 31754102
Nature. 2005 Apr 14;434(7035):864-70
pubmed: 15829956
PLoS One. 2014 Nov 21;9(11):e112945
pubmed: 25415278
Cell Rep. 2013 May 30;3(5):1651-62
pubmed: 23684611
J Biol Chem. 2018 Feb 9;293(6):1994-2005
pubmed: 29279331
Trends Mol Med. 2017 Oct;23(10):899-916
pubmed: 28899755
Circ Res. 2008 Mar 28;102(6):703-10
pubmed: 18239138
J Cell Biol. 2014 Aug 18;206(4):493-507
pubmed: 25113031
Nat Rev Neurosci. 2012 Jul;13(7):465-77
pubmed: 22678511
Cancer Res. 2018 Dec 15;78(24):6713-6716
pubmed: 30498082
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
F1000Res. 2017 Nov 14;6:2010
pubmed: 29333246
Cancer Res. 2011 Mar 15;71(6):2308-17
pubmed: 21406402
Bioinformatics. 2017 Feb 1;33(3):414-424
pubmed: 27694195
Cell Rep. 2017 Jan 31;18(5):1229-1240
pubmed: 28147277
Theranostics. 2017 Mar 22;7(5):1346-1359
pubmed: 28435470
Trends Pharmacol Sci. 2018 Mar;39(3):307-325
pubmed: 29254698
DNA Repair (Amst). 2019 Jun;78:128-141
pubmed: 31039537
Anal Chem. 2003 Sep 1;75(17):4646-58
pubmed: 14632076
EMBO J. 2016 Jul 15;35(14):1488-503
pubmed: 27225932
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Cancer Res. 2013 Jun 1;73(11):3225-34
pubmed: 23548271
J Neurooncol. 2017 Sep;134(3):541-549
pubmed: 28357536

Auteurs

Megan R Reed (MR)

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Leena Maddukuri (L)

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Amit Ketkar (A)

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Stephanie D Byrum (SD)

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Maroof K Zafar (MK)

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

April C L Bostian (ACL)

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Alan J Tackett (AJ)

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Robert L Eoff (RL)

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Classifications MeSH